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Background—Optical coherence tomography (OCT) is an optical imaging method that produces
high-resolution cross-sectional images of the esophagus. The accuracy of OCT for differentiating
tissue types at the squamocolumnar junction (SCJ) has not been established.
Objective—The purpose of this study was to identify and validate OCT image criteria for
distinguishing metaplastic from nonmetaplastic tissue at the SCJ.
Design—A total of 196 biopsy-correlated OCT images of the SCJ were acquired from 113 patients
undergoing upper endoscopy. A pathologist blinded to the OCT results reviewed each pathology
specimen and determined the presence of the following histopathology: gastric cardia, squamous
mucosa, pancreatic metaplasia, and intestinal metaplasia. An algorithm for diagnosing specialized
intestinal metaplasia (SIM) was created by reviewing a training set of 40 biopsy-correlated OCT
images. Two blinded investigators prospectively tested the algorithm on a validation set of 123
images.
Results—OCT images of squamous mucosa were characterized by a layered appearance without
epithelial glands; gastric cardia, by vertical pit and gland structure, a well-defined epithelial surface
reflectivity, and relatively poor image penetration; and SIM by an irregular architecture and good
image penetration. The OCT criteria were 85% sensitive and 95% specific for SIM when applied
retrospectively to the training set. When applied to the validation set, the algorithm was 81% sensitive
for both OCT readers and 66% and 57% specific for diagnosing SIM. The interobserver agreement
was good (κ = 0.53).
Conclusions—OCT imaging can identify SIM at the SCJ with an accuracy similar to that of
endoscopy.
GERD is a well-known risk factor for the development of specialized intestinal metaplasia
(SIM) of the esophagus, commonly known as Barrett's esophagus (BE).1 The prevalence of
SIM has been estimated to be as high as 10% to 15% in patients with chronic GERD.2 For a
patient with recurrent and severe symptoms of GERD, the adjusted odds ratio for developing
adenocarcinoma over a 20-year period is 7.7 and 43.5, respectively.3 Moreover, the incidence
of esophageal adenocarcinoma and proximal stomach (gastric cardia) cancers have rapidly
increased during the last 30 years.4-6 Because of the recognition of GERD as a risk factor for
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tdeveloping esophageal cancer, upper endoscopic screening is recommended for white, male
patients older than 50 years who have had chronic symptoms of GERD for more than 5 years.
7 Endoscopic evaluation of the esophagus, with subsequent biopsy of regions suspicious for
being metaplastic, is the only accepted method for diagnosing BE. The accuracy of this method
is not ideal. Endoscopists correctly identify SIM in only 40% of cases, and the fractional area
of tissue sampled by biopsy is small.8,9 A medical decision analysis performed to assess the
cost-effectiveness of endoscopy for screening for SIM and high-grade dysplasia in patients
with GERD concluded that the expense of endoscopy was one of the most important factors
when determining whether or not screening was cost effective.10 This analysis found that
screening for SIM would be justified if the cost of the screening method was significantly lower
than the present cost of endoscopy.10 Alternative screening methods that provide greater
esophageal-area coverage than conventional biopsy should improve the accuracy of detecting
SIM. Furthermore, new methods carry the potential to reduce cost, thus partially alleviating
the financial burden of comprehensive screening on the health care system.
Optical coherence tomography (OCT) is an optical imaging modality that uses near-infrared
light to produce high-resolution (10-μm axial resolution) cross-sectional images of GI mucosa.
Images are constructed based on light reflectivity in relation to the properties of the substrate
being visualized. OCT can readily identify structures on a microscopic scale, including mucosal
layers, “pit and gland” morphology, and glandular structure.11,12 A previous study
demonstrated that OCT can distinguish SIM from squamous, fundic, and antral mucosa but
can falsely identify gastric cardia as SIM.13 This prior study used biopsy-correlated images
obtained throughout the upper-GI tract and as a result did not address the accuracy of OCT
specifically at the squamocolumnar junction (SCJ), which is the region where SIM is thought
to originate.
Four mucosal types typically populate the SCJ: gastric cardia or oxyntocardia, serous
pancreatic metaplasia, squamous epithelia, and SIM.14,15 For OCT to be a reliable, sensitive,
and cost-effective screening instrument, characterization of epithelial architecture at the SCJ
should be accurate enough to distinguish premalignant (SIM) from benign tissue. The aim of
this study was to identify and validate OCT image criteria of SIM, permitting its distinction
from nonmetaplastic tissue at the gastroesophageal junction.
PATIENTS AND METHODS
Design
The study was a blinded, prospective trial. Its primary objective was to identify and validate
OCT image features for differentiating intestinal metaplasia at the SCJ. Patients who were
undergoing routine outpatient upper endoscopy were asked to participate in the study. OCT
images of the SCJ were obtained during endoscopy. Two pathologists reviewed each biopsy
specimen and noted the presence of the following tissue types: gastric or oxyntic cardia,
squamous mucosa, or pancreatic metaplasia. The existence of intestinal metaplasia was
characterized histologically by the presence of goblet cells. OCT image features of intestinal
metaplasia were determined by creating and reviewing an OCT “training set,” which contained
biopsy-correlated images of known tissue types. These features were then prospectively
applied to a “validation set” of unknown tissue types. The sensitivity, the specificity, and the
reproducibility of the image criteria for diagnosis of intestinal metaplasia were determined.
OCT system
The OCT device was described in previous studies.13,16 The light source center wavelength
was 1300 nm, and the optical power incident on the tissue was 5.0 mW. The spectral bandwidth
of the source was 70 nm, which provided an axial resolution of 10 μm. The catheter diameter
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twas 2.5 mm. Images were acquired in a linear longitudinal plane, with dimensions of 5.5 mm
(1000 pixels) in length and 2.5 mm (500 pixels) in depth. During image acquisition, frames
were recorded at a rate of 2 per second and were numbered sequentially for reference. A visible
aiming laser coincident with the imaging beam allowed the endoscopist to localize the site of
mucosa undergoing image acquisition, which facilitated biopsy correlation of the imaged site.
Endoscopy and subject recruitment
The protocol was reviewed and approved by the institutional review board at Massachusetts
General Hospital. Recruited subjects included patients who were undergoing routine upper
endoscopy and patients with known short-segment (<1 cm) intestinal metaplasia without
known dysplasia at the gastroesophageal junction. Data were collected between November
2003 and September 2004. Subjects underwent routine upper endoscopy with conscious
sedation and oropharyngeal anesthesia. A standard gastroscope (model EG 3470K; Pentax
Medical, Tokyo, Japan), with a 3.8-mm instrument channel, was used.
OCT imaging
Written informed consent was obtained before the procedure. After adequate sedation and
oropharyngeal anesthesia were achieved, an upper endoscopy was performed. The endoscopist
identified the SCJ at the gastroesophageal junction or Barrett's segment. An OCT catheter probe
was introduced through the instrument channel of the endoscope and advanced to the SCJ.
Immediately distal to the SCJ, OCT images were acquired and recorded at the mucosal site
marked by the visible aiming beam, and 1 jumbo biopsy specimen (with a 3.3-mm diameter
biopsy forceps; Microvasive Endoscopy, Boston Scientific Corp. Natick, Mass) was obtained.
OCT frames that corresponded to the imaged site were documented. Two biopsy-correlated
images per patient were obtained. Acquisition of a biopsy-correlated image required
approximately 30 seconds.
Histopathology
The biopsy specimens were placed in 10% formalin, embedded in paraffin, processed routinely,
and stained with H&E.
Description of pathology review
A pathologist reviewed each biopsy specimen and determined the presence of the following
epithelial types: gastric cardia, squamous mucosa, serous pancreatic metaplasia, and SIM. A
single diagnosis was rendered for biopsy specimens that contained multiple histologic types.
For the purposes of this study, cardia mucosa and oxyntocardiac mucosa were grouped together
as gastric cardia.
OCT image analysis
A “training set” that consisted of 20 randomly selected biopsy-correlated images of SIM and
20 randomly selected biopsy-correlated images of other tissue types were created. Two
investigators (J.A.E., G.J.T.) familiar with OCT reviewed the training set and determined
diagnostic image criteria for SIM. These criteria were then prospectively applied to a
“validation set” that comprised the remainder of the data set. All OCT images in the validation
set were reviewed to ensure image clarity, stripped of identifying information, and randomly
allocated by investigators (J.B., B.B.) not involved with the determination of the diagnostic
criteria. Images were removed from the data set if they were determined to be of poor quality,
demonstrated linear artifacts caused by friction encountered by the OCT beam-scanning
device, or failed to display adequate tissue within the image.
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The histopathologic diagnoses of the training set are shown in Table 1. Squamous epithelium
was distinguished by a layered epithelium without glands (Fig. 1A). Gastric cardia was
characterized by the presence of “pit and gland” morphology, regular surface architecture, the
presence of a highly reflecting epithelial surface, or poor image penetration (Fig. 1B). For cases
with a layered architecture, SIM was distinguished by the presence of epithelial glands (Fig.
2). In cases without layered architecture and “pit and gland” morphology, irregular surface
architecture, lack of a highly reflecting epithelial surface, or good light penetration further
differentiated SIM from the columnar epithelium of gastric cardia and ectopic pancreas (Fig.
3). A diagnostic algorithm for identifying SIM at the SCJ was formulated with these image
criteria (Fig. 4).
When the diagnostic algorithm was retrospectively applied to the training set, it was 85%
sensitive (95% confidence interval [CI] 75%-95%) and 95% specific (95% CI 88%-100%) for
differentiating SIM from nonmetaplastic tissue at the SCJ.
Validation set
Of the 156 biopsy-correlated images that comprised the validation set, 33 were excluded
because of poor image quality, leaving a total of 123 biopsy-correlated images for prospective
analysis. The histopathology included in the validation set and excluded because of inadequate
image quality are detailed in Table 2. When 2 blinded OCT readers applied the diagnostic flow
chart (Fig. 4) to the validation set, the algorithm was found to be 81% (95% CI 58%-95%) and
81% (95% CI 58%-95%) sensitive, and 66% (95% CI 56%-75%) and 57% (95% CI 47%-67%)
specific for a diagnosis of SIM at the SCJ. The agreement between the 2 readers was good
(κ = 0.53). The truth tables for the 2 OCT readers are depicted in Table 3. The histologic
breakdown of the 79 false-positive and the 125 true-negative results is presented in Table 4.
The histopathology of images when discrepant diagnoses were rendered by the OCT readers
is described in Table 5.
DISCUSSION
This study identified specific OCT image characteristics that can distinguish intestinal
metaplasia from benign, normal mucosa at the SCJ in a cohort of patients undergoing routine
upper endoscopy. Although there is moderate variability in this distinction, a diagnostic
sensitivity of 81% for SIM compares favorably with that of published endoscopic sensitivities
(82%).17 Our results strengthen the growing body of literature that describes the ability of OCT
to distinguish tissue types on a histologic scale.18,19
The diagnostic flow chart accurately identified SIM when retrospectively applied to the training
set, but the accuracy declined when prospectively applied to the validation set. Potential
explanations of this difference in accuracy are inadequate tissue representation with the training
set, registration error, and architectural distortion. The histologic diagnosis of SIM requires
the identification of goblet cells on routine H&E staining of esophageal biopsy specimens.
Because current OCT systems cannot resolve individual goblet cells, the image characteristics
of intestinal metaplasia based on tissue architecture needed to be determined. Gastric cardia
and SIM comprised 17.5% and 50% of the training set, respectively. The analyzed validation
set, however, contained 29% and 17% of gastric cardia and of SIM, respectively. It is possible
that the training set did not provide an adequate representation of the variability of gastric
cardia images, thereby reducing the overall OCT image accuracy. The accuracy of registration
of biopsy sampling and image acquisition during the endoscopic procedure is difficult to
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testimate. Errors on the order of a few millimeters were likely and may have contributed to
misdiagnosis by OCT. Histologic architectural changes, although sensitive for intestinal
metaplasia, are not perfectly accurate; are seen in nonmetaplastic columnar mucosa; and when
solely relied upon for a histologic diagnosis, could lead to significant errors in accuracy.
Support for this hypothesis is shown in Table 4, which shows that gastric cardia (n = 31) and
columnar epithelia (n = 24) tissue types accounted for the majority (70%) of false positives.
Precision of SIM diagnosis between readers, however, was excellent. A discrepant diagnosis
of SIM was rendered only twice, whereas columnar epithelia (cardia and columnar) for
histologic diagnosis accounted for 7 and 12 discrepant diagnoses (Table 5).
The majority of images removed from the validation set were those that corresponded to a
histologic diagnosis of the SCJ and the cardia (Table 2). Reasons for poor image acquisition
of these areas are not completely understood but may be due to physical constraints of the OCT
catheter within the working channel as torque is applied to the endoscope. Motion artifact from
a moving esophagus is also a potential source of image distortion. Further study into OCT
imaging of the SCJ is ongoing and may provide additional insights. Efforts to improve the
OCT devices to minimize the percentage of poor quality images are also necessary.
There was good agreement between the observers' diagnoses of intestinal metaplasia (κ = 0.53),
though there are no published data quantifying interobserver agreement of OCT image
interpretation in the esophagus. For this study, we attempted to generate relatively simple
diagnostic criteria to maintain reproducibility. It is possible that greater agreement between
OCT and histopathology could arise from a more intricate scoring system. Future studies with
more complex diagnostic criteria and larger data sets may be warranted to improve the accuracy
of this technique.
A previous study examined OCT image features of SIM, squamous mucosa, and gastric
mucosa.13 In contrast to this previous study, where tissue samples were taken randomly from
the esophagus and the stomach, biopsy-correlated images in our study were performed only at
the SCJ, thereby including a much higher proportion of image samples of gastric cardia and
columnar epithelium. The proportional increase in columnar epithelium in this data set likely
accounts for the differences in the determined sensitivities for SIM. Our study supports and
confirms the ability of OCT to distinguish SIM by using a simple subjective visual assessment.
This is a significant step in the application of OCT as a screening technique in the treatment
and care of patients with GERD.
Before broad acceptance of OCT as a valid screening technique for detecting SIM in patients
with GERD, further research in 3 areas will be needed. First, a system must be developed to
deliver the OCT catheter to the esophageal lining in a simple manner that is comfortable to the
patient and applicable to a large population. Second, dysplasia in BE will need to be easily and
accurately identifiable. Third, computer-software-aided image processing and classification
algorithms to allow easier interpretation of data by the practicing gastroenterologist will need
to be generated. Finally, these applications and results must be reproducible on a large scale.
Current OCT technology is rapidly advancing. High-resolution systems that produce better
than 5-mm resolution are on the horizon.20,21 If these efforts are successful and if the criteria
are sufficiently accurate, OCT may be used to comprehensively screen the SCJ without
endoscopy, thus avoiding the costs of endoscopy, biopsy preparation, and pathology review.
These technologic improvements may propel OCT to the forefront of optical biopsy
technologies as a first-line screening technique in the management of GERD.
Capsule Summary
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tWhat is already known on this topic
•OCT produces high-resolution, cross-sectional images of the esophagus, but its accuracy
for differentiating tissue types at the SCJ has not been established.
What this study adds to our knowledge
•In a blinded prospective study that used an algorithm for diagnosing SIM and a validation
set of 123 biopsy-correlated OCT images, a diagnostic sensitivity of 81% for SIM indicated
that OCT imaging can identify SIM at the SCJ with accuracy similar to that of endoscopy.
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Images of nonmetaplasic epithelium. A, OCT image of squamous epithelium demonstrates a
horizontally layered architecture. B, OCT image of gastric cardia shows regular, vertical “pit
and gland” architecture, a highly scattering epithelial surface, and relatively poor image
penetration. Scale bars, 500 μm.
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Images of SIM with a layered architecture. A, Horizontal layered architecture can be visualized
in this OCT image of SIM. Glands present in the superficial layer (arrows) differentiate this
tissue from squamous epithelium. B, Corresponding histology (H&E, orig. mag. ×100). Scale
bars, 500 μm.
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Images of SIM without a layered architecture. A, Absence of a layered or regular “pit and
gland” architecture, low superficial epithelial reflectivity, and relatively good image
penetration are characteristic of SIM at the SCJ. B, Corresponding histology (H&E, orig. mag.
×40). Scale bars, 500 μm.
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Diagnostic algorithm flowchart for differentiating SIM at the SCJ.
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TABLE 1
Histology breakdown of training set
Histology type No. in training set Percentage of whole
Intestinal metaplasia 20 50
Gastric cardia 7 50
Squamous mucosa 0 0
Squamocolumnar 10 25
Columnar* 2 25
Pancreatic tissue 1 2.5
Total 40 100
*
Columnar epithelium, not metaplastic, not cardia.
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TABLE 2
Histology included and excluded from validation set
Histology type No. analyzed in validation set No. (%) excluded because of poor image
quality
Intestinal metaplasia 21 5 (9)
Cardia* 36 11 (23)
Squamous mucosay† 6 2 (25)
Squamocolumnar 22 9 (29)
Columnarz‡ 37 5 (12)
Pancreatic tissue 1 1 (50)
Total 123 33
*
Cardia, oxyntocardia, and carditis.
†
Squamous mucosa and esophagitis.
‡
Columnar epithelium, gastritis, gastric body, glandular mucosa.












































































Truth table Nonmetaplastic Intestinal metaplasia Total
GT truth table
Diagnosis from OCT
image Nonmetaplastic 67 4 71
Intestinal metaplasia 35 17 52
Total 102 21 123
JE truth table
Diagnosis from OCT
image Nonmetaplastic 58 4 62
Intestinal metaplasia 44 17 61
Total 102 21 123
GT, Dr Tearney; JE, Dr Evans.
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TABLE 4
Histologic breakdown of false positives and true negatives
False positives True negatives
Cardia* 31 41
Squamous mucosa† 6 6
Squamocolumnar 16 28
Columnar‡ 24 50
Pancreatic tissue 2 0
Total 79 125
*
Cardia, oxyntocardia, and carditis.
†
Squamous mucosa and esophagitis.
‡
Columnar epithelium, gastritis, gastric body, glandular mucosa.
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TABLE 5
Breakdown of discrepant diagnoses by OCT readers









Cardia, oxyntocardia, and carditis.
†
Squamous mucosa and esophagitis.
‡
Columnar epithelium, gastritis, gastric body, glandular mucosa.
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